You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘percutaneous coronary intervention’
January 2008
Br J Cardiol 2008;15:12
Correspondence
Does the transradial route for percutaneous coronary intervention preclude the use of the radial artery as a conduit for
January 2008
Br J Cardiol 2008;15:21
Subacute stent thrombosis within a paclitaxel-eluting stent
A 60-year-old male was admitted acutely unwell with prolonged ischaemic chest pain. Seven weeks earlier he had undergone percutaneous coronary intervention (PCI) following admission with
September 2007
Br J Cardiol 2007;14:234-6
Stent thrombosis and antiplatelet therapy: a review of 3,004 consecutive patients in a single centre
Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary intervention (PCI), and is associated with the discontinuation of antiplatlet therapy. In a
September 2007
Br J Cardiol 2007;14:293-95
The Venture TM wire control catheter
The presence of severe vessel tortuosity, extreme angulation of side-branch ostia, stent jail, or lack of control at the interface of chronic total occlusions can
May 2007
Br J Cardiol 2007;14:129-30
Protecting the heart by postconditioning
Coronary heart disease (CHD) is the leading cause of death in the UK (accounting for 105,000 deaths in 2004) and exerts a huge burden, both
July 2006
Br J Cardiol (Acute Interv Cardiol) 2006;13:AIC 39–AIC 45
Estimating the risk of percutaneous coronary intervention
Percutaneous coronary intervention (PCI) is expanding in terms of both the numbers of patients treated and the scope and severity of coronary artery disease tackled.
March 2006
Br J Cardiol (Acute Interv Cardiol) 2006;13:AIC 9–AIC 12
Percutaneous coronary intervention of the right ventricular artery: is it worth the effort?
Loss of the right ventricular artery (RVA) is generally thought to be of little consequence. Nonetheless, reperfusion can enhance right ventricular recovery and improve the
November 2005
Br J Cardiol (Acute Interv Cardiol) 2005;12:AIC 81–AIC 82
Percutaneous coronary interventions in West Yorkshire for the year 2002: an audit
Early invasive management in patients with unstable angina and non-ST elevation myocardial infarct (NSTEMI) is now well established. However, patients can wait for weeks at
July 2005
Br J Cardiol (Acute Interv Cardiol) 2005;12:AIC 49–AIC 53
Diabetic revascularisation by coronary angioplasty: is one stent better than another?
As confidence in the use of drug-eluting stents (DES) increases, they are being used in patients with progressively more complex disease. Diabetes is still an
November 2004
Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 85–AIC 88
Bivalirudin in percutaneous coronary intervention
Bivalirudin is a direct thrombin inhibitor that will be available in the UK in November 2004 as adjunctive anticoagulant therapy during percutaneous coronary intervention (PCI).